Literature DB >> 20495082

Medullary carcinoma.

R Michael Tuttle1, Douglas W Ball, David Byrd, Gilbert H Daniels, Raza A Dilawari, Gerard M Doherty, Quan-Yang Duh, Hormoz Ehya, William B Farrar, Robert I Haddad, Fouad Kandeel, Richard T Kloos, Peter Kopp, Dominick M Lamonica, Thom R Loree, William M Lydiatt, Judith McCaffrey, John A Olson, Lee Parks, John A Ridge, Jatin P Shah, Steven I Sherman, Cord Sturgeon, Steven G Waguespack, Thomas N Wang, Lori J Wirth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20495082     DOI： 10.6004/jnccn.2010.0040

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  24 in total

1.  Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.

Authors:  Allen S Ho; Lu Wang; Frank L Palmer; Changhong Yu; Arnbjorn Toset; Snehal Patel; Michael W Kattan; R Michael Tuttle; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2014-11-04       Impact factor: 5.344

2.  Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma.

Authors:  Domenico Rubello; Ka Kit Wong; Maria Cristina Marzola; Mohsen Beheshti; Valentina Ambrosini; Sotirios Chondrogiannis; Milton D Gross
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04       Impact factor: 9.236

3.  Sporadic medullary thyroid carcinoma with a pedunculated intraluminal internal jugular vein recurrence: A case report and literature review.

Authors:  Darren K Patten; Rashpal Flora; Neil Tolley; Fausto Palazzo
Journal:  Int J Surg Case Rep       Date:  2011-11-22

4.  Treating medullary thyroid carcinoma in a tertiary center. Current trends and review of the literature.

Authors:  E Prokopakis; M Doulaptsi; A Kaprana; S Velegrakis; Y Vlastos; G Velegrakis
Journal:  Hippokratia       Date:  2014-04       Impact factor: 0.471

Review 5.  Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.

Authors:  C M Thomas; S L Asa; S Ezzat; A M Sawka; D Goldstein
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

Review 6.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

7.  Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: long-term follow-up.

Authors:  Giuseppe Barbesino; Melanie Goldfarb; Sareh Parangi; Jingyun Yang; Douglas S Ross; Gilbert H Daniels
Journal:  Thyroid       Date:  2012-03-02       Impact factor: 6.568

Review 8.  Management of medullary thyroid carcinoma and MEN2 syndromes in childhood.

Authors:  Steven G Waguespack; Thereasa A Rich; Nancy D Perrier; Camilo Jimenez; Gilbert J Cote
Journal:  Nat Rev Endocrinol       Date:  2011-08-23       Impact factor: 43.330

9.  The results of molecular genetic testing for RET proto-oncogene mutations in patients with medullary thyroid carcinoma in a referral center after the two decade period.

Authors:  B Rovcanin; S Damjanovic; V Zivaljevic; A Diklic; M Jovanovic; I Paunovic
Journal:  Hippokratia       Date:  2016 Jul-Sep       Impact factor: 0.471

10.  Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).

Authors:  Bruno Niederle; Frédéric Sebag; Michael Brauckhoff
Journal:  Langenbecks Arch Surg       Date:  2013-12-03       Impact factor: 3.445
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.